Treatment of granuloma annulare with tofacitinib
| dc.contributor.author | Bosch Amate, Xavier | |
| dc.contributor.author | Serra García, Laura | |
| dc.contributor.author | Alamon Reig, Francesc | |
| dc.contributor.author | Martí Martí, Ignasi | |
| dc.contributor.author | Gil Lianes, Javier | |
| dc.contributor.author | Giavedoni, Priscila | |
| dc.contributor.author | Mascaró Galy, José Manuel | |
| dc.date.accessioned | 2024-11-21T20:25:38Z | |
| dc.date.available | 2024-11-21T20:25:38Z | |
| dc.date.issued | 2022-08-01 | |
| dc.date.updated | 2024-11-21T20:25:38Z | |
| dc.description.abstract | Granuloma annulare (GA) is a granulomatous, idiopathic, inflammatory skin disorder characterized by the formation of papules and plaques with annular and acral distribution. GA is often limited and self-resolving, but in some cases, it can be generalized and refractory to treatments. New advances in the pathophysiology of GA have favoured Janus kinase (JAK) inhibitors as a promising therapeutic option.1,2 Here, we report three cases of resistant generalized GA successfully treated with tofacitinib. | |
| dc.format.extent | 4 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 751574 | |
| dc.identifier.issn | 0004-8380 | |
| dc.identifier.pmid | 35605155 | |
| dc.identifier.uri | https://hdl.handle.net/2445/216669 | |
| dc.language.iso | eng | |
| dc.publisher | Wiley | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1111/ajd.13875 | |
| dc.relation.ispartof | Australasian Journal of Dermatology, 2022, vol. 63, num.3, p. 400-403 | |
| dc.relation.uri | https://doi.org/10.1111/ajd.13875 | |
| dc.rights | cc-by (c) Bosch Amate, Xavier et al., 2022 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0 | * |
| dc.source | Articles publicats en revistes (Medicina) | |
| dc.subject.classification | Malalties de la pell | |
| dc.subject.classification | Inhibidors enzimàtics | |
| dc.subject.classification | Resposta immunitària | |
| dc.subject.classification | Medicaments | |
| dc.subject.other | Skin diseases | |
| dc.subject.other | Enzyme inhibitors | |
| dc.subject.other | Immune response | |
| dc.subject.other | Drugs | |
| dc.title | Treatment of granuloma annulare with tofacitinib | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1